CORE LABORATORIES INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $6.0M | $-789.0K | $14.2M | $10.6M | $-154.0K | $11.7M | $9.0M | $3.2M |
| Depreciation & Amortization | $3.8M | $3.8M | $3.6M | $3.7M | $3.7M | $3.7M | $3.8M | $3.8M |
| Depreciation | $3.7M | $3.6M | $3.5M | $3.6M | $3.6M | $3.6M | $3.6M | $3.7M |
| Amortization | $140.0K | $208.0K | $65.0K | $109.0K | $124.0K | $125.0K | $127.0K | $128.0K |
| Stock-Based Compensation | — | $5.0M | — | — | $4.2M | — | — | $4.8M |
| Net Cash from Operating Activities | $7.8M | $4.0M | $8.5M | $13.9M | $6.7M | $13.1M | $17.1M | $5.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $4.7M | $3.4M | $2.0M | $3.5M | $2.8M | $2.7M | $2.9M | $3.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-3.4M | — | — | $772.0K | — | — | $-1.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | $460.0K | — | — | $469.0K | — | — | $468.0K |
| Stock Repurchases | — | $4.0M | — | — | $2.0M | — | — | $44.0K |
| Net Cash from Financing Activities | — | $-457.0K | — | — | $-4.5M | — | — | $-4.1M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $3.1M | $517.0K | $6.5M | $10.4M | $3.9M | $10.4M | $14.3M | $2.5M |